Gérard Helft

7.8k total citations
104 papers, 3.7k citations indexed

About

Gérard Helft is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Gérard Helft has authored 104 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Cardiology and Cardiovascular Medicine, 53 papers in Surgery and 32 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Gérard Helft's work include Coronary Interventions and Diagnostics (34 papers), Cardiac Imaging and Diagnostics (31 papers) and Acute Myocardial Infarction Research (26 papers). Gérard Helft is often cited by papers focused on Coronary Interventions and Diagnostics (34 papers), Cardiac Imaging and Diagnostics (31 papers) and Acute Myocardial Infarction Research (26 papers). Gérard Helft collaborates with scholars based in France, United States and Australia. Gérard Helft's co-authors include Stephen G. Worthley, Juan J. Badimón, Valentı́n Fuster, Zahi A. Fayad, Azfar Zaman, Roberto Corti, John T. Fallon, Michele Mercuri, Claude Le Feuvre and James H. Chesebro and has published in prestigious journals such as New England Journal of Medicine, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Gérard Helft

101 papers receiving 3.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gérard Helft France 25 1.7k 1.6k 1.6k 1.4k 278 104 3.7k
Parham Eshtehardi United States 26 1.7k 1.0× 2.0k 1.2× 1.1k 0.7× 1.0k 0.7× 135 0.5× 69 3.0k
Hyuck Moon Kwon South Korea 30 1.9k 1.1× 1.8k 1.1× 917 0.6× 645 0.5× 267 1.0× 171 3.8k
Shiro Uemura Japan 35 1.9k 1.1× 2.5k 1.6× 1.5k 0.9× 1.0k 0.7× 241 0.9× 197 4.5k
Michiel Voskuil Netherlands 34 1.7k 1.0× 1.6k 1.0× 1.1k 0.7× 430 0.3× 231 0.8× 149 3.5k
Atsushi Tanaka Japan 36 2.1k 1.2× 3.4k 2.1× 2.4k 1.5× 1.3k 0.9× 241 0.9× 182 4.5k
Dietrich Baumgart Germany 33 2.8k 1.6× 2.8k 1.7× 2.0k 1.2× 1.6k 1.1× 85 0.3× 147 4.9k
Takahiko Suzuki Japan 42 2.8k 1.7× 4.5k 2.8× 3.1k 1.9× 1.7k 1.2× 133 0.5× 189 5.7k
Vicente Bodı́ Spain 33 2.5k 1.5× 860 0.5× 1.7k 1.1× 324 0.2× 139 0.5× 206 3.6k
Miodrag Ostojić Serbia 30 2.4k 1.4× 1.5k 0.9× 1.2k 0.8× 394 0.3× 64 0.2× 202 3.5k
Adrian F. Low Singapore 24 1.8k 1.0× 1.1k 0.7× 657 0.4× 426 0.3× 381 1.4× 113 3.0k

Countries citing papers authored by Gérard Helft

Since Specialization
Citations

This map shows the geographic impact of Gérard Helft's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gérard Helft with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gérard Helft more than expected).

Fields of papers citing papers by Gérard Helft

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gérard Helft. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gérard Helft. The network helps show where Gérard Helft may publish in the future.

Co-authorship network of co-authors of Gérard Helft

This figure shows the co-authorship network connecting the top 25 collaborators of Gérard Helft. A scholar is included among the top collaborators of Gérard Helft based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gérard Helft. Gérard Helft is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Olié, Valérie, Clémence Grave, Gérard Helft, et al.. (2024). Epidemiology of cardiovascular risk factors: Behavioural risk factors. Archives of cardiovascular diseases. 117(12). 770–784. 4 indexed citations
2.
Recher, Morgan, François Javaudin, Tahar Chouihed, et al.. (2023). Bystander basic life support and survival after out-of-hospital cardiac arrest: A propensity score matching analysis. The American Journal of Emergency Medicine. 67. 135–143. 7 indexed citations
3.
Zeitouni, Michel, Niki Procopi, Paul Guedeney, et al.. (2022). Beta-blocker prescription and outcomes in uncomplicated acute myocardial infarction: Insight from the ePARIS registry. Archives of cardiovascular diseases. 116(1). 25–32. 4 indexed citations
4.
Mavrakanas, Thomas A., Yiannis S. Chatzizisis, Karim Gariani, et al.. (2019). Duration of Dual Antiplatelet Therapy in Patients with CKD and Drug-Eluting Stents. Clinical Journal of the American Society of Nephrology. 14(6). 810–822. 22 indexed citations
6.
Sharma, Abhishek, Carl J. Lavie, Gérard Helft, et al.. (2016). Role of Vorapaxar After Coronary Revascularization. The American Journal of Cardiology. 117(7). 1059–1064. 1 indexed citations
8.
Barthélemy, Olivier, Dan Tolédano, Shaïda Varnous, et al.. (2012). Multislice computed tomography to rule out coronary allograft vasculopathy in heart transplant patients. The Journal of Heart and Lung Transplantation. 31(12). 1262–1268. 11 indexed citations
9.
Barthélémy, Olivier, Gérard Helft, Johanne Silvain, et al.. (2011). One-year clinical outcomes in patients with chronic renal failure treated by percutaneous coronary intervention with drug-eluting stent. Archives of cardiovascular diseases. 104(12). 604–610. 12 indexed citations
10.
Helft, Gérard, Claude Le Feuvre, & B. Wechsler. (2008). Left ventricular aneurysm in Behçet's disease. Archives of cardiovascular diseases. 101(5). 375–375. 1 indexed citations
11.
Feuvre, Claude Le, Gérard Helft, Sheldon Cohen, et al.. (2008). Characteristics and prognosis of patients with angiographic stent thrombosis: comparison between drug-eluting and bare-metal stents. Archives of cardiovascular diseases. 101(4). 220–225. 5 indexed citations
12.
Feuvre, Claude Le, Yann Allali, Jean Collet, et al.. (2008). Medium-term survival after primary angioplasty for myocardial infarction complicated by cardiogenic shock after the age of 75 years. Archives of cardiovascular diseases. 101(3). 175–180. 8 indexed citations
13.
Zhang, Zhuangyu, Josef Macháč, Gérard Helft, et al.. (2006). Non-invasive imaging of atherosclerotic plaque macrophage in a rabbit model with F-18 FDG PET: a histopathological correlation. PubMed. 6(1). 3–3. 97 indexed citations
14.
Feuvre, Claude Le, Anne Batisse, Jean‐Philippe Collet, et al.. (2006). Cardiac events after low osmolar ionic or isosmolar nonionic contrast media utilization in the current era of coronary angioplasty. Catheterization and Cardiovascular Interventions. 67(6). 852–858. 15 indexed citations
15.
Corti, Roberto, Gérard Helft, Juan F. Viles-González, et al.. (2005). Effects of Aggressive Versus Conventional Lipid-Lowering Therapy by Simvastatin on Human Atherosclerotic Lesions. Journal of the American College of Cardiology. 46(1). 106–112. 193 indexed citations
16.
Feuvre, Claude Le, et al.. (2003). Comparison of short- and long-term outcomes of coronary angioplasty in patients with and without diabetes mellitus and with and without hemodialysis. The American Journal of Cardiology. 92(6). 721–725. 16 indexed citations
17.
Regnault, Véronique, Gérard Helft, D. Wahl, et al.. (2003). Antistreptokinase platelet-activating antibodies are common and heterogeneous. Journal of Thrombosis and Haemostasis. 1(5). 1055–1061. 3 indexed citations
18.
Helft, Gérard, Stephen G. Worthley, Valentı́n Fuster, et al.. (2001). Atherosclerotic aortic component quantification by noninvasive magnetic resonance imaging: an in vivo study in rabbits. Journal of the American College of Cardiology. 37(4). 1149–1154. 79 indexed citations
20.
Worthley, Stephen G., Gérard Helft, Azfar Zaman, Valentı́n Fuster, & Juan J. Badimón. (2000). Atherosclerosis and the vulnerable plaque ‐ pathogenesis: Part I. Australian and New Zealand Journal of Medicine. 30(5). 600–607. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026